Financial Ratios

REGENT CHEMICALS LTD.

NSE : NABSE : 506989ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2004Mar2003Mar2002Mar2001Mar2000
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.36-0.38-0.40-0.38-0.45
   CEPS(Rs)0.00-0.01-0.04-0.02-0.09
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.391.752.132.532.91
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)
   EBIT Margin(%)
   Pre Tax Margin(%)
   PAT Margin (%)
   Cash Profit Margin (%)
Performance Ratios
   ROA(%)-16.27-14.53-13.45-11.33-11.93
   ROE(%)-22.90-19.41-17.19-14.00-14.46
   ROCE(%)-20.65-17.82-15.23-12.84-13.32
   Asset Turnover(x)0.000.000.000.000.00
   Sales/Fixed Asset(x)0.000.000.000.000.00
   Working Capital/Sales(x)0.000.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)
   Receivable days
   Inventory Days
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)
   EV/Core EBITDA(x)-7031.35-686.15-488.24-848.29-130.23
   EV/EBIT(x)-28.26-27.03-26.61-27.28-22.91
   EV/CE(x)5.054.223.673.212.88
   M Cap / Sales
Growth Ratio
   Net Sales Growth(%)
   Core EBITDA Growth(%)90.2528.84-73.4484.65-108.91
   EBIT Growth(%)4.401.57-2.3616.01-187.05
   PAT Growth(%)4.435.89-5.1015.94-196.20
   EPS Growth(%)4.435.89-5.1015.94-196.20
Financial Stability Ratios
   Total Debt/Equity(x)0.120.100.080.080.07
   Current Ratio(x)0.480.520.540.650.68
   Quick Ratio(x)0.480.520.540.650.68
   Interest Cover(x)0.00-3022.47-21.64-52.78-55.27
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.